FDA label 0a1c9bec-694b-412c-bfcf-2ff4df19f53c

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
e58e52c4-50f9-4727-9950-bfefadabb2d0
SPL ID
0a1c9bec-694b-412c-bfcf-2ff4df19f53c
Version
3
Effective date
2012-05-02
Source export date
2026-09-28
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:12:50

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

WARNINGS If pain or fever persists, if new symptoms occur, or if redness or swelling is pre- sent, consult your physician immediately because these could be signs of a serious condition. Do not give this product to children under 12 years of age unless directed by a physician. Caution should be exercised when used in patients with pro-static hypertrophy, urinary retention, bladder neck obstruction, increased ocular pressure, and asthma. PRECAUTIONS Information for Patients: Patient consultation should include the following information regarding the proper use of NOREL® SR: • Do not exceed recommended dosage. • May be taken with food, water, or milk to lessen gastric irritation. • Do not drive or operate heavy machinery if drowsi- ness or dizziness occurs. • Concomitant use of alcohol and other central nervous system depressants (hypnotics, sedatives, tranquilizers and anti- anxiety drugs) while tak ing NOREL® SR may have an additive effect on drowsiness. • If a dose is missed, the medication should be taken as soon as possible unless it is almost time for the next dose. Doses should not be doubled. • Swallow extended-release tablets whole; do not crush or chew tablets prior to swallowing.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The following adverse effects have been selected on the basis of their potential clinical significance (not necessarily inclusive): allergic reactions, anemia, blood dyscrasias (sore throat and fever, unusual bleeding or bruising, unusual tiredness or weakness), psychotic episodes (mood or mental changes) – usually associated with previous history of psychiatric illness, tightness in chest.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.